Hosting Call at 5:00 pm ET on Tuesday, November 29th
European Q&A Session on November 30th at 8:30am
ET
CALGARY,
AB, Nov. 15, 2022 /CNW/ - Nanalysis Scientific
Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1, a leader
in portable NMR machines and MRI technology for healthcare and
industrial applications announces that on Tuesday, November
29th, 2022, the Company will put out a press release and Chief
Executive Officer Sean Krakiwsky and
Interim Chief Financial Officer Randall
McRae will host a conference call at 5:00 P.M. Eastern Time to discuss the results for
the quarter ending September 30,
2022.
Investors interested in participating on the live second quarter
call can dial 1-888-664-6392 or 416-764-8659 from abroad. Investors
can also access the call online through a listen-only webcast here:
https://app.webinar.net/JoLVkw4jEmX or on the investor
relations section of the Company's website HERE.
The webcast will be archived on the Company's investor relations
webpage for at least 90 days and a telephonic playback will be
available for seven days after the conference call by calling
1-888-390-0541 or 416-764-8677, conference ID #833132.
Additionally, the Company will be hosting a Q&A session for
it's European investors at 8:30am ET on Wednesday, November 30th which can be
accessed by the following link: Click here to join the meeting, or
call in (audio only) +1 437-703-4522, Phone Conference ID: 295 204
525#.
About Nanalysis Scientific
Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA:1N1)
Nanalysis trades on the TSX Venture Exchange (TSXV)
in Canada with ticker symbol 'NSCI', OTC and
the Frankfurt exchange under the ticker symbol '1N1'. The
company's business is what we term "MRI and NMR for industry". The
company develops and manufactures portable Nuclear Magnetic
Resonance (NMR) spectrometers or analyzers for laboratory and
industrial markets. The NMReady-60™ was the first full-feature
portable NMR spectrometer in a single compact enclosure requiring
no liquid helium or any other cryogens. The company has followed-up
that initial offering with new products and continues to have a
strong innovation pipeline. Nanalysis recently announced that it
has begun selling a 100MHz device in 2020. The Company's new device
will be the most powerful and most advanced compact NMR device ever
brought to market.
Nanalysis devices are used in many industries (oil and gas,
chemical, mining, pharma, biotech, flavor and fragrances,
agrochemicals, law enforcement, and more) as well as numerous
government and university research labs around the world. The
Company continues to exploit new global market opportunities
independently and with partners.
With the recent acquisition of K'(Prime) Technologies Inc.
(KPrime), the company maintains a North American sales and service
company of over 40 individuals who cover scientific instrumentation
for pharma, food, chemical and oil & gas customers, as well as
imaging systems for security applications.
Additionally, the Company has a 43% ownership in Quad Systems AG
("Quad Systems"), with an option to purchase the remaining shares.
Quad Systems is a Zurich-based Nuclear Magnetic Resonance
(NMR) company focused on high-field NMR for pharmaceutical and
other vertical markets.
Notice regarding Forward Looking Statements and Legal
Disclaimer
This news release contains certain
"forward-looking statements" within the meaning of such statements
under applicable securities law. Forward-looking statements are
frequently characterized by words such as "anticipates", "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed", "positioned"
and other similar words, or statements that certain events or
conditions "may" or "will" occur. These statements are only
predictions. Various assumptions were used in drawing the
conclusions or making the projections contained in the
forward-looking statements throughout this news release.
Forward-looking statements are based on the opinions and estimates
of management at the date the statements are made and are subject
to a variety of risks and uncertainties and other factors that
could cause actual events or results to differ materially from
those projected in the forward-looking statements. The Company is
under no obligation, and expressly disclaims any intention or
obligation, to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise,
except as expressly required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services
Provider accepts responsibility for the adequacy or accuracy of
this release.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nanalysis-announces-third-quarter-2022-conference-call-301678454.html
SOURCE Nanalysis Scientific Corp.